BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36842076)

  • 1. [The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries].
    Salukhov VV; Arutyunov GP; Tarlovskaya EI; Batluk TI; Bashkinov RA; Samus IV; Melnikov ES; Trubnikova MA; Arutyunov AG
    Probl Endokrinol (Mosk); 2023 Feb; 69(1):36-49. PubMed ID: 36842076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries].
    Arutyunov AG; Tarlovskaya EI; Galstyan GR; Batluk TI; Bashkinov RA; Arutyunov GG; Belenkov YN; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Butomo MI; Vaisberg AR; Galyavich AS; Gomonova VV; Grigoryeva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Zateishchikova AA; Kamilova UK; Kim ZF; Kuznetsova TY; Kulikov AN; Lareva NAV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanov DY; Saiganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Schukarev DA; Abdrakhmanova AK; Avetisyan SA; Avoyan HG; Azaryan KK; Aimakhanova GT; Ayypova DA; Akunov AC; Alieva MK; Almukhambedova AR; Aparkina AV; Aruslanova OR; Ashina EY; Badina ONY; Barysheva OY; Batchaeva AS; Bitieva AM; Bikhteev IU; Borodulina NA; Bragin MV; Brazhnik VA; Budu AM; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Galova EA; Genkel VV; Giller DB; Gorshenina EI; Grigoryeva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duishobaev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybaeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karsiev MK; Kaskaeva DS; Kasymova KF; Kerimbekova ZB; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kozlov SV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondryakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordyukova VA; Koroleva EV; Kraposhina AY; Kryukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kuranova IAM; Kurenkova LVV; Kurchugina NY; Kushubakova NA; Levankova VI; Ledyaeva AA; Lisun TV; Lisyanskaya VE; Lyubavina NA; Magdeeva NA; Mazalov KV; Mayseenko VI; Makarova AS; Maripov AM; Markov NV; Marusina AA; Melnikov ES; Metlinskaya AI; Moiseenko NB; Muradova FN; Muradyan RG; Musaelyan SN; Nekaeva ES; Nikitina NM; Nifontov SE; Obolentseva EY; Obukhova AA; Ogurlieva BB; Odegova AA; Omarova YV; Omurzakova NA; Ospanova SO; Pavlova VA; Pakhomova EVP; Petrov LD; Plastinina SS; Platonov DA; Pogrebetskaya VAA; Polyakov DV; Polyakov DS; Ponomarenko EEV; Popova LL; Potanin AA; Prokofieva NA; Rabik YD; Rakov NA; Rakhimov AN; Rozanova NA; Samus IV; Serikbolkyzy S; Sidorkina YA; Simonov AA; Skachkova VV; Skvortsova RD; Skuridin DS; Solovieva DV; Solovieva IA; Sukhomlinova IM; Sushilova AG; Tagaeva DR; Titoykina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostyanetskaya NAA; Trofimov DA; Trubnikova MA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TSI; Shavrin IV; Shevchenko OA; Shikhaliev DR; Shishkina EA; Shishkov KY; Shcherbakov SY; Shcherbakova GV; Yausheva EA
    Probl Endokrinol (Mosk); 2023 Jan; 68(6):89-109. PubMed ID: 36689715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of type 2 diabetes mellitus and acute cardiovascular disorders in patients with early disturbances of carbohydrate metabolism].
    Dreval' AV; Misnikova IV; Barsukov IA; Dzebisashvili GT
    Klin Med (Mosk); 2012; 90(11):30-4. PubMed ID: 23516850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients.
    Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C
    Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in patients with non-ST-segment elevation acute coronary syndrome concurrent with type 2 diabetes mellitus (according to the results of the registry)].
    Golikov AP; Berns SA; Stryuk RI; Shmidt EA; Golikova AA; Barbarash OL
    Ter Arkh; 2017; 89(3):65-71. PubMed ID: 28378733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study.
    Shah P; Magee K; Buccellato KH; Ismond M; Watson J
    Cardiovasc Diabetol; 2022 Feb; 21(1):24. PubMed ID: 35164745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both?
    Ergelen M; Uyarel H; Cicek G; Isik T; Osmonov D; Gunaydin ZY; Bozbay M; Turer A; Gul M; Abanonu GB; Ilhan E
    Acta Cardiol; 2010 Aug; 65(4):415-23. PubMed ID: 20821934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders].
    Strongin LG; Nekrasova TA; Belikina DV; Korneva KG; Petrov AV
    Probl Endokrinol (Mosk); 2022 Feb; 68(2):56-65. PubMed ID: 35488757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
    Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
    Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of blood biomarkers in prospective follow-up of patients with cardiovascular pathology in combination with type 2 diabetes mellitus after COVID-19 associated pneumonia.
    Petelina TI; Musikhina NA; Garanina VD; Shcherbinina AE; Kalyuzhnaya EN; Sharoyan YA; Kapustina AA; Gapon LI; Yaroslavskaya EI
    Klin Lab Diagn; 2022 Oct; 67(10):561-569. PubMed ID: 36315170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.
    Martorina WJ; Tavares A
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):18-21. PubMed ID: 34259775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outpatient diagnosis of oxidant stress in patients with carbohydrate metabolism disturbance in metabolic syndrome].
    Romanenko IA; Poliatykina TS; Budnikova NV; Tomilova IK; Akaĭzin ES; Pakhrova OA; Arkhipova SL
    Ter Arkh; 2005; 77(6):68-72. PubMed ID: 16078605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.
    Hardy YO; Libhaber E; Ofori E; Amenuke DAY; Kontoh SA; Dankwah JA; Larsen-Reindorf R; Otu-Ansah C; Hutton-Mensah K; Dadson E; Adamu S; Akyerekoh K; Sarfo FS; Nkum B
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e391. PubMed ID: 36426913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA.
    Paolisso P; Foà A; Bergamaschi L; Angeli F; Fabrizio M; Donati F; Toniolo S; Chiti C; Rinaldi A; Stefanizzi A; Armillotta M; Sansonetti A; Magnani I; Iannopollo G; Rucci P; Casella G; Galiè N; Pizzi C
    Cardiovasc Diabetol; 2021 Sep; 20(1):192. PubMed ID: 34560876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status.
    Mondal S; DasGupta R; Lodh M; Garai R; Choudhury B; Hazra AK; Mondal A; Ganguly A
    Diabetes Res Clin Pract; 2022 Aug; 190():109974. PubMed ID: 35809688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.